Skip to content

Evaluation of pulmonary vascular disease in patients with Long Covid and dyspnea

Dr. Jason Weatherald and other researchers from the Department of Medicine at the University of Calgary are conducting a research study. Long COVID Syndrome (Long COVID) is defined by persistent symptoms (including breathlessness, chest pain and fatigue) after COVID-19 illness that continue for more than 12 weeks and cannot be explained by another diagnosis. The goal of this project is to explore the underlying cause of the ongoing symptoms of patients suffering from Long COVID.

You are invited to participate in this research study, if you have ongoing symptoms after COVID-19, would like to volunteer as a person who has recovered from COVID-19 or you have pulmonary vascular disease of another type. Your participation in this research study is voluntary.

Taking part in this study will require you to complete some tests used to find out the cause of unexplained shortness of breath in patients including a Chest x-ray, Pulmonary function tests, Cardiopulmonary exercise test (CPET) and Right Heart Catheterization (RHC) with exercise. If you are interested in the study please call at 403-210-7861 to get more information about the study.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
You can participate in the study if you are at least 18 years old and have
1) tested positive for COVID-19 more than 12 weeks ago and still feel short of breath.
OR
2) tested positive for COVID-19 more than 12 weeks ago and have fully recovered with no symptoms at present
OR
3) you have been diagnosed with Pulmonary Hypertension previously, with or without having COVID-19


Exclusion Criteria:
You cannot participate in the study if you are
1) unable to perform exercise due to joint problems and/or chronic pain
2) have abnormal Chest x-ray, Echocardiography or Pulmonary function tests
3) have been diagnosed with Atrial Fibrillation or recent Pulmonary Embolism
4) Pregnant or breast feeding
5) Body mass index (BMI) > 45 kg/m2

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB21-1381